Sharp Shalini bought NBIX
May 17, 2024 · Form 4 insider transaction
Sharp Shalini bought 2,100 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,100
Price
$0.00
Total value
N/A
InsiderSharp Shalini
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 17, 2024
Filing dateMay 21, 2024
Shares owned after2,100
OwnershipDirect
10b5-1 planNo
AmendedNo